1/4
About Polydex

As far back as 1969, we have been engaged in the manufacture of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry as well as the manufacture and marketing of biotechnology-based products for human pharmaceutical markets. Business is conducted through our wholly-owned subsidiaries, Dextran Products in Canada and Chemdex in the United States.

 

Common Shares

 

Shares Issued & Outstanding  -  3,425,978

An OTC Pink Foreign Issuer - POLXF

​Electronically Quoted with OTC Markets

Fiscal Year End  -  January 31st

Currently a SEC non-reporting issuer 

Recent News

 

June 15, 2020

Polydex Pharmaceuticals Ltd.

Issues First Quarter Financial Results

 

Company Remains Profitable During Global Reduction in Business

Polydex Pharmaceuticals

Investor Relations

Find us

 Limited

Contact:



Linda C. Hughes
Polydex Investor Relations
 

E-Mail PolydexIR@gmail.com

Copyright 2020 All Rights Reserved  Polydex Pharmaceuticals Limited.